Literature DB >> 25502080

Down-regulation of miR-24-3p in colorectal cancer is associated with malignant behavior.

Yang Gao1, Yimin Liu, Lutao Du, Juan Li, Ailin Qu, Xin Zhang, Lili Wang, Chuanxin Wang.   

Abstract

Deregulation of microRNAs is a frequent event in the tumorigenesis and tumor progression. The aim of this study was to investigate the clinical significance and potential role of miR-24-3p expression in colorectal cancer (CRC). The expression level of miR-24-3p was determined in 95 CRC patients who underwent radical resection by quantitative real-time PCR. The associations between miR-24-3p expression and clinicopathological parameters were analyzed. In vitro function assays including cell proliferation, cell migration and invasion were further explored. We found that miR-24-3p was reduced in CRC tissues compared with their corresponding non-cancerous tissues (P < 0.001) and significantly correlated with local invasion (P = 0.002), lymph node metastasis (P = 0.0007) and clinical stage (P < 0.001). Moreover, Kaplan-Meier survival analysis showed that patients with low miR-24-3p level had a significantly poorer prognosis than those with high miR-24-3p level (P < 0.001). Multivariate analysis revealed that miR-24-3p (HR 2.767; 95 % CI 1.203-6.364; P = 0.017) and clinical TNM stage (HR 0.456; 95 % CI 0.212-0.978; P = 0.044) could be independent prognostic indicators for overall survival rates of CRC patients. In addition, functional assays showed that over-expression of miR-24-3p suppressed CRC cell proliferation, cell migration and invasion. miR-24-3p functions as a tumor suppressor in CRC. Down-regulation of miR-24-3p contributes to the development and progression of CRC and may have a potential role in prognosis and therapy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25502080     DOI: 10.1007/s12032-014-0362-4

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  26 in total

Review 1.  The widespread regulation of microRNA biogenesis, function and decay.

Authors:  Jacek Krol; Inga Loedige; Witold Filipowicz
Journal:  Nat Rev Genet       Date:  2010-07-27       Impact factor: 53.242

2.  Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors.

Authors:  Fatima A Haggar; Robin P Boushey
Journal:  Clin Colon Rectal Surg       Date:  2009-11

3.  A functional variant at miR-24 binding site in B7-H2 alters susceptibility to gastric cancer in a Chinese Han population.

Authors:  Panpan Yang; Rong Tang; Jianjie Zhu; Lingting Zou; Ruirong Wu; Huan Zhou; Yong Mao; Rui Li; Dong Hua; Weipeng Wang; Hongjian Zhang
Journal:  Mol Immunol       Date:  2013-05-18       Impact factor: 4.407

Review 4.  MicroRNAs and cancer: past, present, and potential future.

Authors:  Kristen M Nelson; Glen J Weiss
Journal:  Mol Cancer Ther       Date:  2008-12       Impact factor: 6.261

5.  miR-24 regulates apoptosis by targeting the open reading frame (ORF) region of FAF1 in cancer cells.

Authors:  Wenming Qin; Yi Shi; Botao Zhao; Chengguo Yao; Li Jin; Jiexian Ma; Youxin Jin
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

6.  Preferential star strand biogenesis of pre-miR-24-2 targets PKC-alpha and suppresses cell survival in MCF-7 breast cancer cells.

Authors:  Elizabeth C Martin; Steven Elliott; Lyndsay V Rhodes; James W Antoon; Claire Fewell; Yun Zhu; Jennifer L Driver; Mona Jodari-Karimi; Christopher W Taylor; Erik K Flemington; Barbara S Beckman; Bridgette M Collins-Burow; Matthew E Burow
Journal:  Mol Carcinog       Date:  2012-08-21       Impact factor: 4.784

7.  Altered Runx1 subnuclear targeting enhances myeloid cell proliferation and blocks differentiation by activating a miR-24/MKP-7/MAPK network.

Authors:  Sayyed K Zaidi; Christopher R Dowdy; Andre J van Wijnen; Jane B Lian; Azra Raza; Janet L Stein; Carlo M Croce; Gary S Stein
Journal:  Cancer Res       Date:  2009-10-13       Impact factor: 12.701

8.  miR-24 functions as a tumor suppressor in Hep2 laryngeal carcinoma cells partly through down-regulation of the S100A8 protein.

Authors:  Yan Guo; Weineng Fu; Hong Chen; Chao Shang; Ming Zhong
Journal:  Oncol Rep       Date:  2011-11-30       Impact factor: 3.906

9.  MiR-24 tumor suppressor activity is regulated independent of p53 and through a target site polymorphism.

Authors:  Prasun J Mishra; Bo Song; Pravin J Mishra; Yuan Wang; Rita Humeniuk; Debabrata Banerjee; Glenn Merlino; Jingfang Ju; Joseph R Bertino
Journal:  PLoS One       Date:  2009-12-24       Impact factor: 3.240

10.  Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCC.

Authors:  Alessandro Salvi; Edoardo Abeni; Nazario Portolani; Sergio Barlati; Giuseppina De Petro
Journal:  Int J Oncol       Date:  2012-11-28       Impact factor: 5.650

View more
  27 in total

1.  Platelet microparticles infiltrating solid tumors transfer miRNAs that suppress tumor growth.

Authors:  James V Michael; Jeremy G T Wurtzel; Guang Fen Mao; A Koneti Rao; Mikhail A Kolpakov; Abdelkarim Sabri; Nicholas E Hoffman; Sudarsan Rajan; Dhanendra Tomar; Muniswamy Madesh; Marvin T Nieman; Johnny Yu; Leonard C Edelstein; Jesse W Rowley; Andrew S Weyrich; Lawrence E Goldfinger
Journal:  Blood       Date:  2017-05-12       Impact factor: 22.113

2.  miR-24-3p stimulates migration, invasion and proliferation of prostate cancer cells by targeting suppressor of cytokine signaling 6.

Authors:  Yang Lin; Huifang Cao; Yuxin Tian; Xinping Yang; Changdong Zhou; Qifu Zhang
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

3.  Tissue micro-RNAs associated with colorectal cancer prognosis: a systematic review.

Authors:  Igor Lopes Dos Santos; Karlla Greick Batista Dias Penna; Megmar Aparecida Dos Santos Carneiro; Larisse Silva Dalla Libera; Jéssica Enocencio Porto Ramos; Vera Aparecida Saddi
Journal:  Mol Biol Rep       Date:  2021-02-17       Impact factor: 2.316

Review 4.  Versatile role of miR-24/24-1*/24-2* expression in cancer and other human diseases.

Authors:  Sanjukta Mukherjee; Bhagyashree Shelar; Sudhir Krishna
Journal:  Am J Transl Res       Date:  2022-01-15       Impact factor: 4.060

5.  MicroRNA-23a/24-2/27a as a potential diagnostic biomarker for cancer: A systematic review and meta-analysis.

Authors:  Jing Quan; Suyue Liu; Kangfu Dai; Lu Jin; Tao He; Xiang Pan; Yongqing Lai
Journal:  Mol Clin Oncol       Date:  2017-11-08

Review 6.  MicroRNAs: The Link between the Metabolic Syndrome and Oncogenesis.

Authors:  Adriana Fodor; Andrada Luciana Lazar; Cristina Buchman; Brandusa Tiperciuc; Olga Hilda Orasan; Angela Cozma
Journal:  Int J Mol Sci       Date:  2021-06-13       Impact factor: 5.923

7.  Prognostic significance of microRNA miR-24 in cancers: a meta-analysis.

Authors:  Rongqiang Liu; Weihao Kong; Shiyang Zheng; Chenyu Yu; Yajie Yu; Yuling Xu; Linsen Ye; Yi Shao
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

8.  Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.

Authors:  Zanxi Fang; Jing Tang; Yongying Bai; Huayue Lin; Hanyu You; Hongwei Jin; Lingqing Lin; Pan You; Juan Li; Zhang Dai; Xianming Liang; Yuanhui Su; Qing Hu; Fen Wang; Zhong-Ying Zhang
Journal:  J Exp Clin Cancer Res       Date:  2015-08-22

9.  A Polysome-Based microRNA Screen Identifies miR-24-3p as a Novel Promigratory miRNA in Mesothelioma.

Authors:  Stefania Oliveto; Roberta Alfieri; Annarita Miluzio; Alessandra Scagliola; Raissa S Secli; Pierluigi Gasparini; Stefano Grosso; Luciano Cascione; Luciano Mutti; Stefano Biffo
Journal:  Cancer Res       Date:  2018-08-02       Impact factor: 12.701

10.  MicroRNA panel in serum reveals novel diagnostic biomarkers for prostate cancer.

Authors:  Shiyu Zhang; Cheng Liu; Xuan Zou; Xiangnan Geng; Xin Zhou; XingChen Fan; Danxia Zhu; Huo Zhang; Wei Zhu
Journal:  PeerJ       Date:  2021-05-19       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.